Agrawal D K, McNeill J H
Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada.
Can J Physiol Pharmacol. 1987 Nov;65(11):2274-80. doi: 10.1139/y87-360.
We have examined the functional responses to alpha-adrenoceptor agonists (alpha 1-selective: methoxamine and phenylephrine; alpha 2-selective: clonidine and B-HT 920; non-selective: norepinephrine, serotonin and K+ in ring segments of mesenteric artery of control and streptozotocin-induced diabetic spontaneously hypertensive (SHR) and Wistar-Kyoto (WKY) rats. Systolic blood pressure and contractile responses were examined after 12 weeks of diabetes. There was no significant change in the diabetic WKY rats as compared with the control WKY rats. However, diabetic SHR had significantly less hypertension than control SHR. Responses to serotonin and alpha 2-adrenoceptor agonists were augmented significantly in arteries from control SHR animals as compared with vessels from WKY animals. There was no significant difference in the force of contraction generated by other agonists in both nondiabetic groups. Responses to all agonists in WKY diabetic and to methoxamine and K+ in SHR diabetic arteries were increased as compared with their respective controls. ED50 values for each agonist were similar in all groups. Indomethacin (5 microM) shifted the dose-response curve to norepinephrine to the right in arteries from all groups of animals. However, in the diabetic SHR and WKY, there was a significant reduction in norepinephrine maximum response. Nifedipine was more potent in inhibiting the contraction to K+ and serotonin in WKY diabetic arteries as compared with WKY controls. However, nifedipine inhibited the responses to all agonists with equal potency in the control and diabetic SHR vessels. These results suggest the involvement of alpha 2-adrenoceptors and serotonin receptors in the development and (or) the maintenance of hypertension.(ABSTRACT TRUNCATED AT 250 WORDS)
我们研究了对照、链脲佐菌素诱导的糖尿病自发性高血压(SHR)和Wistar-Kyoto(WKY)大鼠肠系膜动脉环段对α-肾上腺素能受体激动剂(α1选择性:甲氧明和去氧肾上腺素;α2选择性:可乐定和B-HT 920;非选择性:去甲肾上腺素、5-羟色胺和K+)的功能反应。糖尿病12周后检测收缩压和收缩反应。与对照WKY大鼠相比,糖尿病WKY大鼠无显著变化。然而,糖尿病SHR的高血压程度明显低于对照SHR。与WKY动物的血管相比,对照SHR动物动脉对5-羟色胺和α2-肾上腺素能受体激动剂的反应显著增强。两个非糖尿病组中其他激动剂产生的收缩力无显著差异。与各自的对照相比,WKY糖尿病大鼠对所有激动剂的反应以及SHR糖尿病动脉对甲氧明和K+的反应均增加。所有组中每种激动剂的半数有效剂量(ED50)值相似。吲哚美辛(5 microM)使所有动物组动脉中去甲肾上腺素的剂量-反应曲线右移。然而,在糖尿病SHR和WKY中,去甲肾上腺素的最大反应显著降低。与WKY对照相比,硝苯地平在抑制WKY糖尿病动脉对K+和5-羟色胺的收缩方面更有效。然而,硝苯地平在对照和糖尿病SHR血管中以同等效力抑制对所有激动剂的反应。这些结果表明α2-肾上腺素能受体和5-羟色胺受体参与了高血压的发生和(或)维持。(摘要截短至250字)